Avanos Medical AVNS United States — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's united states — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's united states — net sales?
- Avanos Medical (AVNS) reported united states — net sales of $130.8M in Q4 2025.
- How has Avanos Medical's united states — net sales changed year-over-year?
- Avanos Medical's united states — net sales decreased by 1.1% year-over-year, from $132.28M to $130.8M.
- What is the long-term trend for Avanos Medical's united states — net sales?
- Over 4 years (2021 to 2025), Avanos Medical's united states — net sales has grown at a 6.1% compound annual growth rate (CAGR), from $412.2M to $523.2M.
- What does united states — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and related services within the United States geographic market. It reflects the company's commercial performance and market penetration in its primary domestic region, serving as a key indicator of demand for its digestive health and pain management product portfolios.